#25 Brexit allowed the UK to foster an improved regulatory space for scientific advancement
As recently covered by The Spectator, a partnership on cancer treatment R&D between the UK Government and BioNTech is only possible due to the post-Brexit regulatory environment that we have been able to foster and develop.